MedTrace Logo

Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma

NCT01200446 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2011-05-26

No results posted yet for this study

Summary

Docosahexaenoic acid (DHA) is a component of fish oil that is known to support a healthy cardiovascular system, maintain brain function, reduce depression, and improve inflammatory diseases. The study hypothesis is that DHA supplementation will diminish exercise-induced bronchoconstriction and airway inflammation as compared to placebo.

Conditions

Interventions

DIETARY_SUPPLEMENT

Docosahexaenoic Acid

8 docosahexaenoic acid (4.0 grams) capsules per day for 3 weeks.

DIETARY_SUPPLEMENT

Placebo Docosahexaenoic Acid

8 placebo docosahexaenoic acid (corn and soy oil blend) capsules per day for 3 weeks.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Timothy D Mickleborough, PhD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01200446 on ClinicalTrials.gov